Terminal Ileitis on CT Rarely Means Crohn’s Disease: What the Imaging Finding Really Tells Doctors

Terminal ileitis seen on a CT scan does not automatically mean Crohn’s disease. A 10-year retrospective study has found that only 16 of 128 patients with CT-detected terminal ileitis were ultimately diagnosed with Crohn’s disease, representing just 12.5% of the study population.

The finding is clinically important because inflammation or thickening around the terminal ileum is often associated with Crohn’s disease. However, the terminal ileum can be affected by a wide range of conditions, including infections, surgical problems and other inflammatory or malignant processes.

The study, conducted at a tertiary hospital using data collected between 2014 and 2024, suggests that clinicians should treat terminal ileitis as an imaging finding rather than a diagnosis. Further clinical assessment, laboratory testing, stool studies and, where appropriate, endoscopic evaluation may be needed to determine the underlying cause.

The research also identified lower albumin levels as an independent factor associated with Crohn’s disease in patients presenting with CT-detected terminal ileitis, while routine inflammatory markers showed limited diagnostic value in distinguishing Crohn’s disease from other causes.

What is terminal ileitis?

The terminal ileum is the final section of the small intestine, connecting to the large intestine at the ileocecal junction. It plays an important role in nutrient absorption, including the absorption of vitamin B12 and bile acids.

Terminal ileitis refers to inflammation involving this portion of the bowel. It may be identified during abdominal imaging, endoscopy or pathological examination.

On CT imaging, terminal ileitis can appear as abnormalities such as bowel-wall thickening or inflammatory changes around the affected segment. These findings can alert clinicians that something is affecting the terminal ileum, but they do not necessarily reveal the underlying cause.

That distinction is particularly important in patients presenting with abdominal pain or altered bowel habits, because many different diseases can produce overlapping symptoms and imaging appearances.

Why terminal ileitis is often linked to Crohn’s disease

Crohn’s disease is a chronic inflammatory bowel disease that can affect any part of the gastrointestinal tract. The terminal ileum is a common site of involvement, making ileal inflammation an important finding when Crohn’s disease is suspected.

However, the relationship works in only one direction. Crohn’s disease can cause terminal ileitis, but terminal ileitis does not prove that a patient has Crohn’s disease.

This is the central message of the new study.

When a radiologist identifies terminal ileitis on CT, the finding should prompt clinicians to consider the patient’s symptoms, medical history, laboratory results and other investigations rather than immediately assigning a diagnosis of inflammatory bowel disease.

What did the 10-year study find?

The researchers reviewed adult patients who had CT-detected terminal ileitis at a single tertiary hospital between 2014 and 2024.

A total of 128 patients were included in the analysis. After further clinical evaluation, only 16 patients were ultimately diagnosed with Crohn’s disease.

That corresponds to 12.5% of the cohort.

The numbers provide a useful clinical perspective. Although Crohn’s disease is an important possibility when terminal ileitis appears on imaging, it accounted for a relatively small proportion of cases in this cohort.

In other words, most patients with CT-detected terminal ileitis had another explanation for the imaging abnormality.

Infections were a major alternative cause

Among patients who did not have Crohn’s disease, infectious causes were the most common identified category, accounting for 27.7% of non-Crohn’s cases.

This finding reinforces the importance of considering infection when a patient presents with abdominal symptoms and inflammation around the terminal ileum.

Several gastrointestinal infections can produce inflammation in the ileocecal region and may mimic inflammatory bowel disease clinically or radiologically.

Stool testing can therefore become an important part of the diagnostic process in selected patients, particularly when the clinical presentation suggests an infectious cause.

Surgical causes were another important explanation

Surgical causes accounted for 17.9% of non-Crohn’s cases in the study.

This is another reason why imaging findings need to be interpreted in their clinical context. A patient with a recent or relevant surgical history may have inflammatory changes that have little to do with Crohn’s disease.

The broader lesson is that radiological abnormalities should not be interpreted independently of the patient’s history. The same CT finding can have different implications depending on what happened before the scan and what symptoms brought the patient to hospital.

Why stool testing can matter

The study found that stool testing within 72 hours of presentation was performed in 48.4% of patients. Among those tested, pathogens were identified in 35.5%.

These findings demonstrate why infectious causes deserve consideration before a patient is labelled with a chronic inflammatory bowel disease.

A diagnosis of Crohn’s disease has long-term implications. It can influence medication choices, monitoring, dietary discussions and future healthcare decisions. If an acute infection can explain the terminal ileitis, distinguishing that infection from chronic inflammatory bowel disease becomes particularly important.

Stool testing is not necessarily required for every patient with terminal ileitis, but the appropriate investigation depends on symptoms, exposure history, clinical severity and the clinician’s assessment.

Endoscopy provided additional information

Endoscopic evaluation was performed in 59 patients, or approximately 46% of the cohort.

Among patients who underwent biopsy, histopathological inflammation was identified in 43.5% of cases.

This highlights another important point: CT, endoscopy and pathology answer related but different questions.

CT can identify structural and inflammatory changes within and around the bowel. Endoscopy allows direct visualisation of the intestinal lining and enables tissue sampling. Histopathology can then provide microscopic evidence of inflammation or other abnormalities.

No single test should necessarily be expected to establish the cause of terminal ileitis in every patient.

Lower albumin may help identify patients with Crohn’s disease

The researchers also looked for clinical and biochemical characteristics that could help distinguish Crohn’s disease from other causes of terminal ileitis.

Lower albumin levels were independently associated with a Crohn’s disease diagnosis after adjustment for other variables.

The reported odds ratio was 0.82, with a 95% confidence interval of 0.72–0.94 and a p-value of 0.004.

Albumin is a blood protein that can be influenced by several aspects of health, including nutritional status and systemic or intestinal inflammatory processes. In the context of this study, lower albumin was associated with greater odds of Crohn’s disease after accounting for other factors.

However, albumin should not be interpreted as a standalone diagnostic test for Crohn’s disease. The finding is better viewed as one piece of information that may contribute to the overall clinical assessment.

Why routine inflammatory markers were not enough

Another notable finding was that routine inflammatory markers had limited diagnostic value for distinguishing Crohn’s disease from other causes of terminal ileitis.

This is clinically relevant because inflammatory markers are frequently used to assess whether inflammation is present.

But identifying inflammation is not the same as identifying its cause.

A patient with an infection can have elevated inflammatory markers, just as a patient with inflammatory bowel disease can. Therefore, an inflammatory marker may support the presence of an inflammatory process without telling clinicians whether Crohn’s disease is responsible.

The study reinforces the importance of avoiding a simplistic diagnostic pathway in which an abnormal scan plus an elevated inflammatory marker is automatically interpreted as Crohn’s disease.

CT findings should be treated as the beginning of the investigation

The most important clinical implication of the study is that CT-detected terminal ileitis should trigger a differential diagnosis rather than an immediate Crohn’s diagnosis.

The differential diagnosis can include infectious causes, surgical conditions and other inflammatory or malignant processes, depending on the patient’s clinical circumstances.

This approach can help prevent premature diagnostic closure, where clinicians stop investigating after identifying the first plausible explanation for an imaging finding.

For gastroenterologists, the challenge is therefore not simply recognising terminal ileitis. It is determining which patients are most likely to have Crohn’s disease and which have another condition that requires a completely different treatment strategy.

Why premature Crohn’s labelling can matter

Misclassifying terminal ileitis as Crohn’s disease is not a trivial issue.

Crohn’s disease is a chronic condition that may require long-term monitoring and, depending on severity and disease characteristics, medications that modify the immune response.

Giving a patient a chronic inflammatory bowel disease diagnosis without sufficient evidence can therefore lead to unnecessary anxiety, investigations and treatment.

Conversely, dismissing persistent symptoms as a temporary infection when Crohn’s disease is actually present can delay appropriate treatment.

The clinical goal is consequently not to minimise Crohn’s diagnoses. It is to identify the correct cause of terminal ileitis as accurately and efficiently as possible.

A useful diagnostic comparison

The study’s most important message for clinicians

The study does not suggest that terminal ileitis is unimportant. Instead, it suggests that its specificity for Crohn’s disease is limited when identified on CT alone.

That distinction can improve diagnostic reasoning.

Rather than asking only, “Does this scan look like Crohn’s disease?”, clinicians can ask a broader set of questions: Is the presentation acute or chronic? Are there features suggesting infection? Is there relevant surgical history? Are there biochemical abnormalities that increase suspicion for chronic inflammatory disease? Does the patient require endoscopic evaluation?

This more structured approach may reduce unnecessary diagnostic anchoring.

What the study cannot tell us yet

The findings are useful, but the study has limitations that should be considered before applying the results universally.

• It was a retrospective study rather than a prospective diagnostic trial.
• It was conducted at a single tertiary hospital, which may limit how directly the findings apply to other healthcare settings.
• The study included 128 patients, making it relatively small for developing a definitive diagnostic algorithm.
• Not every patient underwent the same additional investigations.
• Only a subset underwent stool testing or endoscopic evaluation.

The researchers therefore recommended larger prospective studies to refine diagnostic algorithms and better determine which patients with terminal ileitis are most likely to have Crohn’s disease.

What could improve diagnosis in the future?

The next step is likely to be a more structured combination of clinical, laboratory, stool, imaging and endoscopic information.

A future diagnostic algorithm could potentially identify patients who require rapid gastroenterological assessment while recognising others whose imaging findings are more consistent with an acute or self-limited process.

The study’s finding regarding albumin could become one component of such a model, although it would require validation in larger populations before being used as a predictive tool.

Similarly, better integration of imaging characteristics with clinical information could help determine whether particular patterns of terminal ileitis are more strongly associated with Crohn’s disease than others.

The bigger insight: imaging should guide diagnosis, not replace it

The study illustrates a broader principle that applies well beyond terminal ileitis: an imaging abnormality is not always a diagnosis.

Modern CT scanning can identify subtle abnormalities that were previously difficult to detect. That improves diagnostic capability, but it also creates the possibility of over-interpreting findings without sufficient clinical context.

Terminal ileitis is a good example. The CT scan can reveal that the terminal ileum is inflamed, but the image alone may not explain why.

The most effective diagnostic approach therefore combines imaging with the patient’s history, symptoms, laboratory findings and, when necessary, direct examination of the bowel.

Conclusion

Terminal ileitis on CT rarely means Crohn’s disease on its own. In this 10-year retrospective study of 128 patients, only 12.5% were ultimately diagnosed with Crohn’s disease, while infectious and surgical causes accounted for substantial proportions of non-Crohn’s cases.

The findings reinforce the importance of a broad differential diagnosis when terminal ileitis is detected. Stool testing, endoscopy and histopathological assessment may provide important additional information in appropriately selected patients.

Lower albumin was independently associated with Crohn’s disease in the study, but routine inflammatory markers had limited ability to distinguish Crohn’s disease from other causes.

The most important takeaway is that terminal ileitis should be investigated rather than automatically labelled as Crohn’s disease. Larger prospective studies could help clinicians develop more accurate diagnostic pathways and identify which patients with this common imaging finding truly require an inflammatory bowel disease work-up.